Solventum Corporation SOLV
89.50
0.91
1.03%
as of 25 Sep
- Market cap
- $15.1B
- P/E
- 10.9×
Follow SOLV
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Solventum Corporation (SOLV) P/S ratio
As of 25 September 2026, Solventum Corporation (SOLV) trades at a P/S ratio of 1.9×. Over the past ten years it has ranged from 1.0× (July 2024) to 1.9× (September 2026); the current reading is higher than 98% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.7× | 19.54% |
| FY2024 | 1.4× | (17.76%) |
| FY2023 | 1.7× | 0.00% |
| FY2022 | 1.7× | — |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 1.6× | 16.45% |
| Mar 2026 | 1.4× | (16.92%) |
| Dec 2025 | 1.7× | 9.42% |
| Sep 2025 | 1.5× | (3.79%) |
| 10 more quarters | Free account |
Against its own ten years
Low 1.0×
High 1.9×
Ten-year median
1.5×
Current reading's percentile
98
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BAX Baxter International Inc. compare | 1.1× |
| AVTR Avantor, Inc. compare | 1.6× |
| SOLV Solventum Corporation | 1.9× |
| ATR AptarGroup, Inc. compare | 2.0× |
| COO The Cooper Companies, Inc. compare | 2.5× |
| ALGN Align Technology, Inc. compare | 2.5× |
| ALC Alcon compare | 2.9× |
| WST West Pharmaceutical Services, Inc. compare | 7.9× |
| RGEN Repligen Corporation compare | 13.6× |
| Medical Instruments & Supplies industry median | 2.8× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on SOLV
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement